SEARCH

SEARCH BY CITATION

REFERENCES

  • Agranat-Meged AN, Deitcher C, Goldzweig G, Leibenson L, Stein M, Galili-Weisstub E. 2005. Childhood obesity and attention deficit/hyperactivity disorder: A newly described comorbidity in obese hospitalized children. Int J Eat Disord 37(4):357359.
  • Agranat-Meged A, Ghanadri Y, Eisenberg I, Ben NeriahZ, Kieselstein-Gross E, Mitrani-Rosenbaum S. 2008. Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: A newly described expression of MC4R deficiency. Am J Med Genet B Neuropsychiatr Genet 147B(8):15471553.
  • Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J. 2008. Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm 115(2):305315.
  • Albayrak O, Albrecht B, Scherag S, Barth N, Hinney A, Hebebrand J. 2011. Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder. Eur J Pharmacol 660(1):165170.
  • Altfas JR. 2002. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2:9.
  • Anderson SE, Cohen P, Naumova EN, Must A. 2006. Relationship of childhood behavior disorders to weight gain from childhood into adulthood. Ambul Pediatr 6(5):297301.
  • APA. 2000. Manual of mental disorders—DSM-IV-TR (Text Revision). Washington, DC: APA.
  • Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40(8):955962.
  • Bessman MJ, Frick DN, O'Handley SF. 1996. The MutT proteins or “Nudix” hydrolases, a family of versatile, widely distributed, “housecleaning” enzymes. J Biol Chem 271(41):2505925062.
  • Biederman J, Faraone SV, Monuteaux MC, Plunkett EA, Gifford J, Spencer T. 2003. Growth deficits and attention-deficit/hyperactivity disorder revisited: Impact of gender, development, and treatment. Pediatrics 111(5 Pt 1):10101016.
  • Boria I, Garelli E, Gazda HT, Aspesi A, Quarello P, Pavesi E, Ferrante D, Meerpohl JJ, Kartal M, Da Costa L, Proust A, Leblanc T, Simansour M, Dahl N, Fröjmark AS, Pospisilova D, Cmejla R, Beggs AH, Sheen MR, Landowski M, Buros CM, Clinton CM, Dobson LJ, Vlachos A, Atsidaftos E, Lipton JM, Ellis SR, Ramenghi U, Dianzani I. 2010. The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat 31(12):12691279. DOI: 10.1002/humu.21383. PubMed PMID: 20960466.
  • Braet C, Claus L, Verbeken S, Van Vlierberghe L. 2007. Impulsivity in overweight children. Eur Child Adolesc Psychiatry 16(8):473483.
  • Brauner-Osborne H, Krogsgaard-Larsen P. 2000. Sequence and expression pattern of a novel human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 65(2):121128.
  • Chen AY, Kim SE, Houtrow AJ, Newacheck PW. 2010. Prevalence of obesity among children with chronic conditions. Obesity (Silver Spring) 18(1):210213.
  • Cichon S, Winge I, Mattheisen M, Georgi A, Karpushova A, Freudenberg J, Freudenberg-Hua Y, Babadjanova G, Van Den Bogaert A, Abramova LI, et al. 2008. Brain-specific tryptophan hydroxylase 2 (TPH2): A functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet 17(1):8797.
  • Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X, Strohmaier J, Steffens M, Meesters C, Herms S. Weingarten M, et al. 2011. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 88(3):372381.
  • Cortese S, Vincenzi B. 2012. Obesity and ADHD: Clinical and neurobiological implications. Curr Top Behav Neurosci 9:199218.
  • Cortese S, Isnard P, Frelut ML, Michel G, Quantin L, Guedeney A, Falissard B, Acquaviva E, Dalla Bernardina B, Mouren MC. 2007. Association between symptoms of attention-deficit/hyperactivity disorder and bulimic behaviors in a clinical sample of severely obese adolescents. Int J Obes (Lond) 31(2):340346.
  • Curtin C, Bandini LG, Perrin EC, Tybor DJ, Must A. 2005. Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: A chart review. BMC Pediatr 5:48.
  • de Zwaan M, Gruss B, Muller A, Philipsen A, Graap H, Martin A, Glaesmer H, Hilbert A. 2011. Association between obesity and adult attention-deficit/hyperactivity disorder in a German community-based sample. Obes Facts 4(3):204211.
  • Doherty L, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Clinton C, Schneider HE, Sieff CA, Newburger PE, Ball SE, et al. 2010. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet 86(2):222228.
  • Dubnov-Raz G, Perry A, Berger I. 2011. Body mass index of children with attention-deficit/hyperactivity disorder. J Child Neurol 26(3):302308.
  • Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'Arcy M, deBerardinis R, Frackelton E, Kim C, et al. 2010. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15(6):637646.
  • Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H, Kim CE, Robison R, et al. 2012. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 44(1):7884.
  • Erermis S, Cetin N, Tamar M, Bukusoglu N, Akdeniz F, Goksen D. 2004. Is obesity a risk factor for psychopathology among adolescents? Pediatr Int 46(3):296301.
  • Erhart M, Herpertz-Dahlmann B, Wille N, Sawitzky-Rose B, Holling H, Ravens-Sieberer U. 2012. Examining the relationship between attention-deficit/hyperactivity disorder and overweight in children and adolescents. Eur Child Adolesc Psychiatry 21(1):3949.
  • Faraone SV, Mick E. 2010. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 33(1):159180.
  • Faraone SV, Biederman J, Monuteaux M, Spencer T. 2005. Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 15(2):191202.
  • Fleming JP, Levy LD, Levitan RD. 2005. Symptoms of attention deficit hyperactivity disorder in severely obese women. Eat Weight Disord 10(1):e10e13.
  • Franke B, Neale BM, Faraone SV. 2009. Genome-wide association studies in ADHD. Hum Genet 126(1):1350.
  • Freitag CM, Rohde LA, Lempp T, Romanos M. 2010. Phenotypic and measurement influences on heritability estimates in childhood ADHD. Eur Child Adolesc Psychiatry 19(3):311323.
  • Friedel S, Horro FF, Wermter AK, Geller F, Dempfle A, Reichwald K, Smidt J, Bronner G, Konrad K, Herpertz-Dahlmann B, et al. 2005. Mutation screen of the brain derived neurotrophic factor gene (BDNF): Identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. Am J Med Genet Part B 132B(1):9699.
  • Fuemmeler BF, Ostbye T, Yang C, McClernon FJ, Kollins SH. 2011. Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: A population-based study. Int J Obes (Lond) 35(6):852862.
  • Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, et al. 2006. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55(12):33663371.
  • Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, et al. 2006. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 11(2):196205.
  • Hinney A, Vogel CI, Hebebrand J. 2010. From monogenic to polygenic obesity: Recent advances. Eur Child Adolesc Psychiatry 19(3):297310.
  • Hinney A, Scherag A, Jarick I, Albayrak O, Putter C, Pechlivanis S, Dauvermann MR, Beck S, Weber H, Scherag S, et al. 2011. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet Part B 156B(8):888897.
  • Holtkamp K, Konrad K, Müller B, Heussen N, Herpertz S, Herpertz-Dahlmann B, Hebebrand J. 2004. Overweight and obesity in children with attention-deficit/hyperactivity disorder. Int J Obes 28:685689.
  • Hubel R, Jass J, Marcus A, Laessle RG. 2006. Overweight and basal metabolic rate in boys with attention-deficit/hyperactivity disorder. Eat Weight Disord 11(3):139146.
  • Kernie SG, Liebl DJ, Parada LF. 2000. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19(6):12901300.
  • Krawczak M, Nikolaus S, von Eberstein H, Croucher PJ, El Mokhtari NE, Schreiber S. 2006. PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 9(1):5561.
  • Lam LT, Yang L. 2007. Overweight/obesity and attention deficit and hyperactivity disorder tendency among adolescents in China. Int J Obes 31:584590.
  • Lantieri F, Glessner JT, Hakonarson H, Elia J, Devoto M. 2010. Analysis of GWAS top hits in ADHD suggests association to two polymorphisms located in genes expressed in the cerebellum. Am J Med Genet Part B 153B(6):11271133.
  • Li Y, Willer C, Sanna S, Abecasis G. 2009. Genotype imputation. Annu Rev Genomics Hum Genet 10:387406.
  • Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. 2010. MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34(8):816834.
  • Maes HH, Neale MC, Eaves LJ. 1997. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27(4):325351.
  • Manolio TA. 2010. Genomewide association studies and assessment of the risk of disease. N Engl J Med 363(2):166176.
  • Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV. 2008. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am J Med Genet Part B 147B(8):14121418.
  • Mustillo S, Worthman C, Erkanli A, Keeler G, Angold A, Costello EJ. 2003. Obesity and psychiatric disorder: Developmental trajectories. Pediatrics 111(4 Pt 1):851859.
  • Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T, et al. 2008. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B(8):13371344.
  • Neale BM, Medland S, Ripke S, Anney RJ, Asherson P, Buitelaar J, Franke B, Gill M, Kent L, Holmans P, et al. 2010a. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49(9):906920.
  • Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Nguyen TT, Schafer H, Holmans P, et al. 2010b. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49(9):884897.
  • (NICE). 2008. Attention deficit/hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. (Clinical Guide 72). National Institute for Health and Clinical Excellence, London, England. available online at: www.nice.org.uk/CG072
  • Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS, Ma Y. 2009. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity (Silver Spring) 17(3):539544.
  • Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, et al. 2004. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44(4):595600.
  • Pauli-Pott U, Albayrak O, Hebebrand J, Pott W. 2010. Association between inhibitory control capacity and body weight in overweight and obese children and adolescents: Dependence on age and inhibitory control component. Child Neuropsychol 16(6):592603.
  • Pott W, Albayrak Ö, Hinney A, Hebebrand J, Pauli-Pott U. 2013. Successful treatment with atomoxetine of an adolescent boy with attention deficit/hyperactivity disorder, extreme obesity, and reduced melanocortin-4-receptor function. Obesity facts (in press).
  • Ptacek R, Kuzelova H, Paclt I, Zukov I, Fischer S. 2009. Anthropometric changes in non-medicated ADHD boys. Neuro Endocrinol Lett 30(3):377381.
  • Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R. 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15(10):17481757.
  • Rodriguez A. 2010. Maternal pre-pregnancy obesity and risk for inattention and negative emotionality in children. J Child Psychol Psychiatry 51(2):134143.
  • Rodriguez A, Miettunen J, Henriksen TB, Olsen J, Obel C, Taanila A, Ebeling H, Linnet KM, Moilanen I, Jarvelin MR. 2008. Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: Evidence from three prospective pregnancy cohorts. Int J Obes (Lond) 32(3):550557.
  • Safrany ST, Caffrey JJ, Yang X, Bembenek ME, Moyer MB, Burkhart WA, Shears SB. 1998. A novel context for the ‘MutT’ module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase. EMBO J 17(22):65996607.
  • Schimmelmann BG, Friedel S, Dempfle A, Warnke A, Lesch KP, Walitza S, Renner TJ, Romanos M, Herpertz-Dahlmann B, Linder M, et al. 2007. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J Neural Transm 114(4):523526.
  • Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. 1996. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 98(4 Pt 1):763769. PubMed PMID: 8885958.
  • Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, et al. 2002. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144(2):212218.
  • Shinawi M, Sahoo T, Maranda B, Skinner SA, Skinner C, Chinault C, Zascavage R, Peters SU, Patel A, Stevenson RE, et al. 2011. 11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity. Am J Med Genet Part A 155A(6):12721280.
  • Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan J, Magi R, et al. 2010. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42(11):937948.
  • Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE. 1996. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35(11):14601469.
  • Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B. 2006. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry 45(5):527537.
  • Sullivan EL, Nousen EK, Chamlou KA. 2012. Maternal high fat diet consumption during the perinatal period programs offspring behavior. Physiol Behav doi:pii: S0031-9384(12)00328-9. 1016/j.physbeh.2012.07.014. [Epub ahead of print] PubMed PMID: 23085399.
  • Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, et al. 2006. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45(11):13041313.
  • Taylor E, Everitt B, Thorley G, Schachar R, Rutter M, Wieselberg M. 1986a. Conduct disorder and hyperactivity: II. A cluster analytic approach to the identification of a behavioural syndrome. Br J Psychiatry 149:768777.
  • Taylor E, Schachar R, Thorley G, Wieselberg M. 1986b. Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients. Br J Psychiatry 149:760767.
  • Van Lieshout RJ, Taylor VH, Boyle MH. 2011. Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: A systematic review. Obes Rev 12(5):e548e559.
  • Volkow ND, Wang GJ, Tomasi D, Baler RD. 2013. Obesity and addiction: Neurobiological overlaps. Obes Rev 14(1):218.
  • Waring E, Lapane KL. 2008. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: Results from a national sample. Pediatrics 122(1):e1e6.
  • Wichmann HE, Gieger C, Illig T. 2005. KORA-gen—Resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67(Suppl. 1):S26S30.
  • Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. 2003. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6(7):736742.